Melatonin - Constantly discovering hormone;Melatonina - Stale odkrywany hormon

Ginekologia Praktyczna

Volumn 14, Issue 4, 2006, Pages 22-25

  Skałba, Piotr ^a   Szanecki, Wojciech ^a   Cieślik, Katarzyna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Circadian rhythm; Melatonin

Indexed keywords

MELATONIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; BLINDNESS; CANCER; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; EPILEPSY; HORMONE ACTION; HUMAN; HYPERTENSION; INSOMNIA; IRRITABLE COLON; PINEAL BODY;

EID: 33846476604     PISSN: 12316407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Lui LN, Jolley DJ, Dyball R. Electrophysiological evidence for retinal projections to the hypothalamic supraoptic nucleus and its perinuclear zone. J Neuroendocrinol 1997; 9:374-353.
2. Cymbowski B. Zegary biologiczne, PWN, Warszawa 1993.
3. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science 1980; 210: 1267-9.
4. Hanifin JP, Stewart KT, Smith P, Tanner R, Rollag M, Brainard GC. High-intensity red light suppresses melatonin. Chronobiol Int 2006; 23 (1-2): 251-68.
5. Ackermann K, Bux R, Rub U, et al. Characterizations of human melatonin synthesis using autoptic pineal tissue. Endocrinology 2006 Jul; 147 (7): 3235-42.
6. Sewerynek E, Lewiński A. Med Po Dypl 1997; 9.
7. Paakonen T, Makinen TM, Leppaluoto J, et al. Urinary melatonin: a noninvasive method to follow human pineal function as studied in three experimental conditions. J Pineal Res 2006; 40 (2): 110-5.
8. Levoye A, Jockers R, Ayoub AA, et al. Are G protein-coupled receptor heterodimers of physiological relevance? - Focus on melatonin receptors. Chronobiol Int 2006, 23 (1-2): 419-26.
9. Popławski PT, Derkacz RA. Jak działa melatonina? Post Bioch 2003, 49 (1), 9-17.
10. Cagnaci A. Melatonin in relation to physiology in adult humans. J Pineal Res 1996; 21: 200-13.
11. Czeisler CA, Shanan TL, Klerman EB, et al. Suppresion of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med 1995; 332: 6-11.
12. Thompson C, Stinson D, Smith A. Seasonal affective disorder and season-dependent abnormalities of melatonin suppression by light. Nancet 1990; 336: 703.
13. Iguchi H, Kalo K, Ibayashi H. Are dependent reduction in serum-melatonin concentration in healthy human subjects. J Clin Endocrinol Metab 1982; 55: 27.
14. Parry BL, Berga SL, Mostofi N, et al. Plasma melatonin circadian rhytms during the menstrual cycle and after light therapy. J Biol Rhytms 1997; 12 (1): 47-64.
15. Cagnaci A, Paoletti AM, Soldani R, et al. Melatonin enhances the luteinizing hormone and follicle-stilulation hormone response to gonadotropin-releasing hormone in the follicular, but not in the luteal menstrual phase. J Clin Endocrinolo Metab 1995; 80 (4): 1095-9.
16. Bellipani G, Bianchi P, Pierpaoli W, et al. Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study. Exp Gerontol 2001; 36 (2): 297-310.
17. Iwasaki S, Nakazawa K, Sakai J, et al. Melatonin as a local regulator of human placental function. J Pineal Res 2005; 39 (3): 261-5.
18. Aydogan S, Yerrer MB, Goktas A. Melatonin and nitric oxide. J Endocrinol Invest 2006; 29 (3): 281-7.
19. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A reviev of the multiple actions of melatonin on the immune system. Endocrine 2005; 27 (2): 189-200.
20. Fisher TW, Zmijewski MA, Zbytek B, et al. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol 2006; 29 (3): 665-72.
21. Garcia-Santos G, Antolin I, Herrera F, et al. Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 2006; 41 (2): 130-5.
22. Belanger CF, Hennekens CH, Rosner B, Speizer FE. The Nurses" Health Study. Am J Nurs 1978; 78: 1039-40.
23. Buscemi N, Vandermeer B, Hooton N, et al. Efficacy and safety of exogenous melatonin or secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ 2006; 332 (7538): 385-93.
24. Weiss MD, Wasdell MB, Bomben MM, et al. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 2006; 45 (5): 512-9.
25. Grossman E, Laudon M, Yalcin R, et al. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 2006; 119 (10): 898-902.
26. Lu WZ, Gwee KA, Moochhalla S, Ho KY. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2005; 22 (10): 927-34.
27. van der Heijden KB, Smits MG, van Someren EJ, Boudewijn Gunning W. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia. J Sleep Res 2005; 14 (2): 187-94.
28. Gupta M, Aneja S, Kohli K. Add-on melatonin improves sleep behavior in children with epilepsy: randomized, double-blind, placebo-controlled trial. J Child Neurol 2005; 20 (2): 112-5.
29. Campos FL, da Silva-Junior FP, de Bruin VM, de Bruin PF. Melatonin improves sleep in asthma: a randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2004; 170 (9): 947-51. Epub 2004 Aug.
30. Cavallo A, Good WV, Douglas Ris M, Succop P. Dose response to melatonin treatment for disordered sleep rhythm in a blind child. Sleep Med 2002; 3 (2): 159-61.
31. Lissoni P, Chilelli M, Villa S, et al. Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res 2003; 35 (1): 12-5.
32. Cerea G, Vaghi M, Ardizzoia A, et al. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Anticancer Res 2003; 23 (2C): 1951-4.
33. Lissoni P, Malugani F, Bukovec R, et al. Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients. Neuro Endocrinol Lett 2003; 24 (1-2): 83-5.
34. Fischer TW, Burmeister G, Schmidt HW, Eisner P. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol 2004; 150 (2):341-5.
35. Karim A, Tolbert D, Cao C. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia. J Clin Pharmacol 2006; 46 (2): 140-8.
36. Leproult R, Van Onderbergen A, et al. Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol (Oxf). 2005; 63 (3): 298-304.
37. Zemlan FP, Mulchahey JJ, Scharf MB, et al. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial. J Clin Psychiatry. 2005; 66 (3): 384-90.